NIH-funded research Career grant

How hormone therapy affects blood pressure and kidney function in men

Official title: Neural and Renal Contributions to Hypertension with Androgen Deprivation Therapy

Funded at University of Colorado Denver · NIH-10897020 · Data updated 2026-11-12

This study is looking at how hormone therapy for prostate cancer affects blood pressure and kidney health in men, aiming to find ways to help manage blood pressure better during treatment.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$166,201
NIH project number5K01HL164978-02
Project IDNIH-10897020 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are men diagnosed with prostate cancer who are starting androgen deprivation therapy.

Less likely to help

Patients who are not undergoing androgen deprivation therapy or those with conditions unrelated to prostate cancer may not benefit from this research.

What this research studies

This research investigates how androgen deprivation therapy (ADT) influences blood pressure and kidney function in men, particularly those undergoing treatment for prostate cancer. The study focuses on understanding the relationship between testosterone levels, inflammation, and the body's ability to regulate blood pressure. By assessing neural and renal contributions to hypertension, the research aims to identify mechanisms that may lead to better management of blood pressure in patients receiving ADT. Participants will be men diagnosed with prostate cancer who are undergoing this specific therapy.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for managing hypertension in men undergoing hormone therapy.

How similar studies have gone: Previous research has indicated that hormonal changes can significantly impact blood pressure regulation, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Babcock, Matthew C — University of Colorado Denver
  • Study coordinator: Babcock, Matthew C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.